News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here .

Recommended Reading

National Health Council to Host Workshop for Patient Organizations
MDedge Endocrinology
Think about breast cancer surveillance for transgender patients
MDedge Endocrinology
FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Endocrinology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Endocrinology
VIDEO: Few transgender patients desire care in a transgender-only clinic
MDedge Endocrinology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Endocrinology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Endocrinology
RFPs Available for the Study of Three Rare Diseases
MDedge Endocrinology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Endocrinology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Endocrinology